Lehmann F G, Cramer P, Hillert U
Z Gastroenterol. 1980 Apr;18(4):208-15.
In comparison to normal controls (n = 71) the activity of intestinal alkaline phosphatase in feces is reduced in chronic bowel disease using an immunoprecipitation method: patients with Crohns disease (n = 40) or inactive ulcerative colitis (n = 29) demonstrate small changes of fecal intestinal alkaline phosphate activity in comparison to normal controls. Intestinal alkaline phosphatase is reduced in patients with active ulcerative colitis (n = 11) to 50%, in patients with uraemic enteropathy (n = 18) to 30% and in patients with coeliac disease (n = 14) to 20% of the activity observed in normal controls. During cytostatic treatment of malignant tumors, fecal intestinal alkaline phosphatase activity increases as a sign of toxic damage of the intestinal mucosa.
与正常对照组(n = 71)相比,采用免疫沉淀法测定发现,慢性肠道疾病患者粪便中肠碱性磷酸酶的活性降低:克罗恩病患者(n = 40)或非活动期溃疡性结肠炎患者(n = 29)与正常对照组相比,粪便中肠碱性磷酸酶活性变化较小。活动期溃疡性结肠炎患者(n = 11)的肠碱性磷酸酶活性降至正常对照组的50%,尿毒症肠病患者(n = 18)降至30%,乳糜泻患者(n = 14)降至20%。在恶性肿瘤的细胞抑制治疗期间,粪便中肠碱性磷酸酶活性增加,这是肠黏膜毒性损伤的迹象。